Literature DB >> 25964689

Warfarin Re-initiation Gone Awry: A Case of Inadvertent Overdose Mandating Critical INR Management.

Tammy J Bungard1, Angela Gee2.   

Abstract

Entities:  

Year:  2015        PMID： 25964689      PMCID： PMC4414079          DOI： 10.4212/cjhp.v68i2.1443

Source DB:  PubMed          Journal:  Can J Hosp Pharm        ISSN： 0008-4123


× No keyword cloud information.
  28 in total

1.  The duration of anticoagulation bridging therapy in clinical practice may significantly exceed that observed in clinical trials.

Authors:  Jacob P Deerhake; Julie C Merz; Jeanna V Cooper; Kim A Eagle; William P Fay
Journal:  J Thromb Thrombolysis       Date:  2007-04       Impact factor: 2.300

2.  Dosing options for decreasing the time to achieve therapeutic anticoagulation when reinitiating warfarin: a case series.

Authors:  Karen T Schultz; Tammy J Bungard
Journal:  Pharmacotherapy       Date:  2011-08       Impact factor: 4.705

Review 3.  How I treat anticoagulated patients undergoing an elective procedure or surgery.

Authors:  Alex C Spyropoulos; James D Douketis
Journal:  Blood       Date:  2012-08-28       Impact factor: 22.113

4.  Prospective study of the outcomes of ambulatory patients with excessive warfarin anticoagulation.

Authors:  E M Hylek; Y C Chang; S J Skates; R A Hughes; D E Singer
Journal:  Arch Intern Med       Date:  2000-06-12

5.  Treatment of warfarin-associated coagulopathy with oral vitamin K: a randomised controlled trial.

Authors:  M A Crowther; J Julian; D McCarty; J Douketis; M Kovacs; L Biagoni; T Schnurr; J McGinnis; M Gent; J Hirsh; J Ginsberg
Journal:  Lancet       Date:  2000-11-04       Impact factor: 79.321

6.  Clinical outcomes with unfractionated heparin or low-molecular-weight heparin as bridging therapy in patients on long-term oral anticoagulants: the REGIMEN registry.

Authors:  A C Spyropoulos; A G G Turpie; A S Dunn; J Spandorfer; J Douketis; A Jacobson; F J Frost
Journal:  J Thromb Haemost       Date:  2006-06       Impact factor: 5.824

7.  Randomized, placebo-controlled trial of oral phytonadione for excessive anticoagulation.

Authors:  R J Patel; D M Witt; J J Saseen; D J Tillman; D S Wilkinson
Journal:  Pharmacotherapy       Date:  2000-10       Impact factor: 4.705

8.  Risk factors for intracranial hemorrhage in outpatients taking warfarin.

Authors:  E M Hylek; D E Singer
Journal:  Ann Intern Med       Date:  1994-06-01       Impact factor: 25.391

9.  Comparison of oral vs intravenous phytonadione (vitamin K1) in patients with excessive anticoagulation: a prospective randomized controlled study.

Authors:  Aharon Lubetsky; Hagith Yonath; David Olchovsky; Ronen Loebstein; Hillel Halkin; David Ezra
Journal:  Arch Intern Med       Date:  2003-11-10

10.  Low-dose oral vitamin K reliably reverses over-anticoagulation due to warfarin.

Authors:  M A Crowther; D Donovan; L Harrison; J McGinnis; J Ginsberg
Journal:  Thromb Haemost       Date:  1998-06       Impact factor: 5.249
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.